• Équipe EPAR

    L'équipe "Épidémiologie des maladies Allergiques et Respiratoires" est intégrée à l'Unité INSERM UMR-S 1136, Institut Pierre Louis d'Epidémiologie et Santé Publique, regroupe 6 Group Leaders, 12 chercheurs ou enseignants chercheurs,2 personnels techno-administratifs, 3 doctorants et 1 post-doc.

  • Les maladies allergiques et respiratoires

    touchent une partie importante de la population et on leur associe des coûts sociaux et économiques importants. Depuis quelques décennies, la prévalence de ces affections n'a cessé d'augmenter. Les causes et les mécanismes de cet accroissement n'ont pas encore été élucidés. Les travaux menés par l'équipe d'EPidémiologie des maladies Allergiques et Respiratoires (EPAR) ont pour but d'approfondir la recherche étiologique des principales maladies allergiques et respiratoires (rhinite, asthme, BPCO, cancer du poumon...), d'identifier les sujets à risque, et de déterminer les coûts associés. L'hypothèse à la base de ces recherches est que l'augmentation des maladies allergiques et respiratoires est due à la fois à des changements de type environnemental et à des modifications de la « sensibilité » de l'hôte. Dans ce contexte, les facteurs de risque, de susceptibilité et de vulnérabilité sont identifiés.

  • Les axes de recherche

    Les principaux axes de recherche qui vont être développés dans les années à venir sont :

    • Impact de la pollution atmosphérique sur les maladies allergiques et respiratoires.
    • Événements de la vie précoce et développement des maladies allergiques et respiratoires.
    • Dossiers patients via le web (e-BPCO, e-Muco, e-dev...).

    Isabella Annesi-Maesano
    Directeur de Recherche INSERM
  • 1
  • 2
  • 3

Bienvenue sur le site de l'équipe EPAR

1. Agache I, Bilo M, Braunstahl GJ, Delgado L, Demoly P, Eigenmann P, Gevaert P, Gomes E, Hellings P, Horak F, Muraro A, Werfel T, Jutel M. In vivo diagnosis of allergic diseases-allergen provocation tests. Allergy 2015; 70: 355-365.

2. Amat F, St-Pierre P, Bourrat E, Nemni A, Couderc R, Boutmy-Deslandes E, Sahraoui F, Panse I, Bagot M, Fouere S, Just J. Early-Onset Atopic Dermatitis in Children: Which Are the Phenotypes at Risk of Asthma? Results from the ORCA Cohort. Plos One 2015; 10.

3. Annesi-Maesano I. It is not time to lower the guard! European Respiratory Journal 2015; 45: 589-591.

4. Avignon A, Fesler P, Daien C, Costa D, Picot M-C, Roubille F, Sultan A, Viarouge-Reunier C, Attalin V, Badin M, Boegner C, Demoly P, Dauzat M, David M, Lognos B, Morel J, Pasquie J-L, Ribstein J, Granier S, Combe B, Mercier J, Bourret R, Bousquet J. In Process Citation. Presse medicale (Paris, France : 1983) 2015; 44 Suppl 1: S47-54.

5. Baldacci S, Maio S, Cerrai S, Sarno G, Baiz N, Simoni M, Annesi-Maesano I, Viegi G, Study H. Allergy and asthma: Effects of the exposure to particulate matter and biological allergens. Respiratory Medicine 2015; 109: 1089-1104.

6. Bentayeb M, Norback D, Bednarek M, Bernard A, Cai G, Cerrai S, Eleftheriou KK, Gratziou C, Holst GJ, Lavaud F, Nasilowski J, Sestini P, Sarno G, Sigsgaard T, Wieslander G, Zielinski J, Viegi G, Annesi-Maesano I, Study G. Indoor air quality, ventilation and respiratory health in elderly residents Living in nursing homes in Europe. European Respiratory Journal 2015; 45: 1228-1238.

7. Bergmann K-C, Demoly P, Abiteboul K, Zeldin RK. Clinical relevance of house dust mite immunotherapy Reply. Journal of Allergy and Clinical Immunology 2015; 135: 288-289.

8. Bourret R, Bousquet J, Mercier J, Camuzat T, Bedbrook A, Demoly P, Caimmi D, Laune D, Arnavielhe S. MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis. World hospitals and health services : the official journal of the International Hospital Federation 2015; 51: 36-39.

9. Bousquet J, Anto JM, Wickman M, Keil T, Valenta R, Haahtela T, Carlsen KL, van Hage M, Akdis C, Bachert C, Akdis M, Auffray C, Annesi-Maesano I, Bindslev-Jensen C, Cambon-Thomsen A, Carlsen KH, Chatzi L, Forastiere F, Garcia-Aymerich J, Gehrig U, Guerra S, Heinrich J, Koppelman GH, Kowalski ML, Lambrecht B, Lupinek C, Maier D, Melen E, Momas I, Palkonen S, Pinart M, Postma D, Siroux V, Smit HA, Sunyer J, Wright J, Zuberbier T, Arshad SH, Nadif R, Thijs C, Andersson N, Asarnoj A, Ballardini N, Ballereau S, Bedbrook A, Benet M, Bergstrom A, Brunekreef B, Burte E, Calderon M, De Carlo G, Demoly P, Eller E, Fantini MP, Hammad H, Hohman C, Just J, Kerkhof M, Kogevinas M, Kull I, Lau S, Lemonnier N, Mommers M, Nawijn M, Neubauer A, Oddie S, Pellet J, Pin I, Porta D, Saes Y, Skrindo I, Tischer CG, Torrent M, von Hertzen L. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy 2015; 70: 1062-1078.

10. Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps. Expert Opinion on Pharmacotherapy 2015; 16: 913-928.

11. Bousquet J, Kuh D, Bewick M, Standberg T, Farrell J, Pengelly R, Joel ME, Rodriguez Manas L, Mercier J, Bringer J, Camuzat T, Bourret R, Bedbrook A, Kowalski ML, Samolinski B, Bonini S, Brayne C, Michel JP, Venne J, Viriot-Durandal P, Alonso J, Avignon A, Ben-Shlomo Y, Bousquet PJ, Combe B, Cooper R, Hardy R, Iaccarino G, Keil T, Kesse-Guyot E, Momas I, Ritchie K, Robine JM, Thijs C, Tischer C, Vellas B, Zaidi A, Alonso F, Ranberg KA, Andreeva V, Ankri J, Arnavielhe S, Arshad H, Auge P, Berr C, Bertone P, Blain H, Blasimme A, Buijs GJ, Caimmi D, Carriazo A, Cesario A, Coletta J, Cosco T, Criton M, Cuisinier F, Demoly P, Fernandez-Nocelo S, Fougere B, Garcia-Aymerich J, Goldberg M, Guldemond N, Gutter Z, Harman D, Hendry A, Heve D, Illario M, Jeandel C, Krauss-Etschmann S, Krys O, Kula D, Laune D, Lehmann S, Maier D, Malva J, Matignon P, Melen E, Mercier G, Moda G, Nizinkska A, Nogues M, O'Neill M, Pelissier JY, Poethig D, Porta D, Postma D, Puisieux F, Richards M, Robalo-Cordeiro C, Romano V, Roubille F, Schulz H, Scott A, Senesse P, Slagter S, Smit HA, Somekh D, Stafford M, Suanzes J, Todo-Bom A, Touchon J, Traver-Salcedo V, Van Beurden M, Varraso R, Vergara I, Villalba-Mora E, Wilson N, Wouters E, Zins M. Operational definition of Active and Healthy Ageing (AHA): A conceptual framework. Journal of Nutrition Health & Aging 2015; 19: 955-960.

12. Bousquet J, Kuh D, Bewick M, Strandberg T, Farrell J, Pengelly R, Joel ME, Manas LR, Mercier J, Bringer J, Camuzat T, Bourret R, Bedbrook A, Kowalski ML, Samolinski B, Bonini S, Brayne C, Michel JP, Venne J, Viriot-Durandal P, Alonso J, Avignon A, Bousquet PJ, Combe B, Cooper R, Hardy R, Iaccarino G, Keil T, Kesse-Guyot E, Momas I, Ritchie K, Robine JM, Thijs C, Tischer C, Vellas B, Zaidi A, Alonso F, Ranberg KA, Andreeva V, Ankri J, Arnavielhe S, Arshad SH, Auge P, Berr C, Bertone P, Blain H, Blasimme A, Buijs GJ, Caimmi D, Carriazo A, Cesario A, Coletta J, Cosco T, Criton M, Cuisinier F, Demoly P, Fernandez-Nocelo S, Fougere B, Garcia-Aymerich J, Goldberg M, Guldemond N, Gutter Z, Harman D, Hendry A, Heve D, Illario M, Jeandel C, Krauss-Etschmann S, Krys O, Kula D, Laune D, Lehmann S, Maier D, Malva J, Matignon P, Melen E, Mercier G, Moda G, Nizinkska A, Nogues M, O'Neill M, Pelissier JY, Poethig D, Porta D, Postma D, Puisieux F, Richards M, Robalo-Cordeiro C, Romano V, Roubille F, Schulz H, Scott A, Senesse P, Slagter S, Smit HA, Somekh D, Stafford M, Suanzes J, Todo-Bom A, Touchon J, Traver-Salcedo V, Van Beurden M, Varraso R, Vergara I, Villalba-Mora E, Wilson N, Wouters E, Zins M. Operative definition of active and healthy ageing (AHA): Meeting report. Montpellier October 20-21, 2014. European Geriatric Medicine 2015; 6: 196-200.

13. Bousquet J, Malva J, Nogues M, Manas LR, Vellas B, Farrell J, Grp MR. Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015. Journal of the American Medical Directors Association 2015; 16: 1020-1026.

14. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghe B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos PAM, Camuzat T, Carlsen KH, Carr W, Sarabia AMC, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Wagner AF, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioglu B, Gereda JE, Gonzalez Diaz S, Gotua M, Grouse L, Guzman MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JOB, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, N'Goran BK, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LTT, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maurer M, Mavale-Manuel S, Melen E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Moesges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schoell I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Pontal FR, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons FER, Sisul JC, Skrindo I, Smit HA, Sole D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015; 70: 1372-1392.

15. Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical Relevance of Cluster Analysis in Phenotyping Allergic Rhinitis in a Real-Life Study. International Archives of Allergy and Immunology 2015; 166: 231-240.

16. Boutin B, Koskas M, Guillo H, Maingot L, La Rocca M-C, Boule M, Just J, Momas I, Corinne A, Beydon N. Forced expiratory flows' contribution to lung function interpretation in schoolchildren. European Respiratory Journal 2015; 45: 107-115.

17. Bouzigon E, Nadif R, Le Moual N, Dizier MH, Aschard H, Boudier A, Bousquet J, Chanoine S, Donnay C, Dumas O, Gormand F, Jacquemin B, Just J, Margaritte-Jeannin P, Matran R, Pison C, Rage E, Rava M, Sarnowski C, Smit LAM, Temam S, Varraso R, Vignoud L, Lathrop M, Pin I, Demenais F, Kauffmann F, Siroux V. Genetic and environmental factors of asthma and allergy: Results of the EGEA study. Revue Des Maladies Respiratoires 2015; 32: 822-840.

18. Brunekreef B, Kuenzli N, Pekkanen J, Annesi-Maesano I, Forsberg B, Sigsgaard T, Keuken M, Forastiere F, Barry M, Querol X, Harrison RM. Clean air in Europe: beyond the horizon? (vol 45, pg 7, 2015). European Respiratory Journal 2015; 45: 861-861.

19. Brunekreef B, Kuenzli N, Pekkanen J, Annesi-Maesano I, Forsberg B, Sigsgaard T, Keuken M, Forastiere F, Barry M, Querol X, Harrison RM. Clean air in Europe: beyond the horizon? European Respiratory Journal 2015; 45: 7-10.

20. Burte E, Bousquet J, Varraso R, Gormand F, Just J, Matran R, Pin I, Siroux V, Jacquemin B, Nadif R. Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study. Plos One 2015; 10.

21. Buters J, Prank M, Sofiev M, Pusch G, Albertini R, Annesi-Maesano I, Antunes C, Behrendt H, Berger U, Brandao R, Celenk S, Galan C, Grewling L, Jackowiak B, Kennedy R, Rantio-Lehtimaki A, Reese G, Sauliene I, Smith M, Thibaudon M, Weber B, Cecchi L, Grp HW. Variation of the group 5 grass pollen allergen content of airborne pollen in relation to geographic location and time in season. Journal of Allergy and Clinical Immunology 2015; 136: 87-U179.

22. Calderon MA, Cox L, Casale TB, Moesges R, Pfaar O, Malling H-J, Sastre J, Khaitov M, Demoly P. The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey. Allergy Asthma and Clinical Immunology 2015; 11.

23. Calderon MA, Farina H, Duniau S, Demoly PM. Physician-Patient Communication Concerning Allergen Immunotherapy: Impact on Treatment Acceptance and Compliance. Journal of Allergy and Clinical Immunology 2015; 135: AB51-AB51.

24. Calderon MA, Kleine-Tebbe J, Linneberg A, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, Demoly P. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies. The journal of allergy and clinical immunology In practice 2015; 3: 843-855.

25. Calderon MA, Linneberg A, Kleine-Tebbe J, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, Demoly P. Respiratory allergy caused by house dust mites: What do we really know? Journal of Allergy and Clinical Immunology 2015; 136: 38-48.

26. Callec R, Lamy C, Perdriolle-Galet E, Patte C, Heude B, Morel O, Grp EM-CCS. Impact on obstetric outcome of third-trimester screening for small-for-gestational-age fetuses. Ultrasound in Obstetrics & Gynecology 2015; 46: 216-220.

27. Carreiro-Martins P, Rosado-Pinto J, do Ceu Teixeira M, Neuparth N, Silva O, Papoila AL, Khaltaev N, Bousquet J, Annesi-Maesano I. Distribution and etiology of chronic respiratory diseases in primary healthcare departments in Cape Verde. Revue D Epidemiologie Et De Sante Publique 2015; 63: 305-313.

28. Chanoine S, Dumas O, Benmerad M, Pison C, Varraso R, Gormand F, Just J, Le Moual N, Bedouch P, Bousquet J, Kauffmann F, Pin I, Siroux V. Long-term benefits of inhaled corticosteroids in asthma: the propensity score method. Pharmacoepidemiology and Drug Safety 2015; 24: 246-255.

29. Chastang J, Baiz N, Cadwalladder JS, Robert S, Dywer J, Charpin DA, Caillaud D, de Blay F, Raherison C, Lavaud F, Annesi-Maesano I. Postnatal Environmental Tobacco Smoke Exposure Related to Behavioral Problems in Children. Plos One 2015; 10.

30. Chastang J, Baiz N, Cadwallader JS, Robert S, Dywer JL, Charpin DA, Caillaud D, de Blay F, Raherison C, Lavaud F, Annesi-Maesano I. Postnatal Environmental Tobacco Smoke Exposure Related to Behavioral Problems in Children (vol 10, e0133604, 2015). Plos One 2015; 10.

31. Dallongeville A, Le Cann P, Zmirou-Navier D, Chevrier C, Costet N, Annesi-Maesano I, Blanchard O. Concentration and determinants of molds and allergens in indoor air and house dust of French dwellings. Science of the Total Environment 2015; 536: 964-972.

32. D'Amato G, Holgate ST, Pawankar R, Ledford DK, Cecchi L, Al-Ahmad M, Al-Enezi F, Al-Muhsen S, Ansotegui I, Baena-Cagnani CE, Baker DJ, Bayram H, Bergmann KC, Boulet L-P, Buters JTM, D'Amato M, Dorsano S, Douwes J, Finlay SE, Garrasi D, Gomez M, Haahtela T, Halwani R, Hassani Y, Mahboub B, Marks G, Michelozzi P, Montagni M, Nunes C, Oh JJ-W, Popov TA, Portnoy J, Ridolo E, Rosario N, Rottem M, Sanchez-Borges M, Sibanda E, Sienra-Monge JJ, Vitale C, Annesi-Maesano I. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. The World Allergy Organization journal 2015; 8: 25-25.

33. D'Amato G, Vitale C, De Martino A, Viegi G, Lanza M, Molino A, Sanduzzi A, Vatrella A, Annesi-Maesano I, D'Amato M. Effects on asthma and respiratory allergy of Climate change and air pollution. Multidisciplinary respiratory medicine 2015; 10: 39-39.

34. Demoly P, Aubier M, de Blay F, Wessel F, Clerson P, Maigret P. Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica study. Allergy Asthma and Clinical Immunology 2015; 11.

35. Demoly P, Calderon MA, Casale TB, Malling H-J, Wahn U. "The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis". Clinical and translational allergy 2015; 5: 18-18.

36. Demoly P, Lawton S, Villesen H, Virchow JC. Immunotherapy with sq-hdm slit-tablet is effective in the treatment of allergic rhinitis and allergic asthma. Internal Medicine Journal 2015; 45: 16-17.

37. Demoly P, Milgrom H. By the numbers: bringing new drugs for allergic/hypersensitivity diseases to the market. Current Opinion in Allergy and Clinical Immunology 2015; 15: 195-196.

38. Demoly P, Passalacqua G, Calderon MA, Yalaoui T. Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clinical and translational allergy 2015; 5: 44-44.

39. Demoly P, Serrano E, Didier A, Bousquet PJ, Mesbah K. Listening to and understanding French patients with allergic rhinitis: Observatory OPERA. Revue Francaise D Allergologie 2015; 55: 347-355.

40. Deschildre A, Marguet C, Langlois C, Pin I, Rittie J-L, Derelle J, Abou Taam R, Fayon M, Brouard J, Dubus JC, Siret D, Weiss L, Pouessel G, Beghin L, Just J. Real-life long-term omalizumab therapy in children with severe allergic asthma. European Respiratory Journal 2015; 46: 856-859.

41. Dinh-Xuan AT, Annesi-Maesano I, Berger P, Chambellan A, Chanez P, Chinet T, Degano B, Delclaux C, Demange V, Didier A, Garcia G, Magnan A, Mahut B, Roche N. Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory Society. Revue Des Maladies Respiratoires 2015; 32: 193-215.

42. Doan S, Amat F, Gabison EE, Cochereau I, Just J. Experience with the monoclonal anti IgE antibody Omalizumab in severe refractory vernal keratoconjunctivitis in children. Investigative Ophthalmology & Visual Science 2015; 56.

43. Fontaine C, Amat F, Paluel-Marmont C, Couderc R, Louha M, Annesi-Maesano I, Bernard A, Just J. Could serum pneumoproteins be new biomarkers for asthma phenotypes in infants? Revue Francaise D Allergologie 2015; 55: 312-316.

44. Foucher F, Hibrand-Saint Oyant L, Hamama L, Sakr S, Nybom H, Baudino S, Caissard JP, Hokanson SC, Byrne DM, Smulder JMS, Desnoye B, Debener T, Bruneau A, De Riek J, Matsumoto S, Torres A, Millan T, Amaya I, Yamada K, Wincker P, Zamir D, Gouzy J, Sargent D, Bendahmane M, Raymond O, Vergne P, Dubois A, Just J. Towards the Rose Genome Sequence and Its Use in Research and Breeding. In: Debener T, Linde M, editors. Vi International Symposium on Rose Research and Cultivation; 2015. p. 167-175.

45. Garcia-Aymerich J, Benet M, Saeys Y, Pinart M, Basagana X, Smit HA, Siroux V, Just J, Momas I, Ranciere F, Keil T, Hohmann C, Lau S, Wahn U, Heinrich J, Tischer CG, Fantini MP, Lenzi J, Porta D, Koppelman GH, Postma DS, Berdel D, Koletzko S, Kerkhof M, Gehring U, Wickman M, Melen E, Hallberg J, Bindslev-Jensen C, Eller E, Kull I, Carlsen KCL, Carlsen KH, Lambrecht BN, Kogevinas M, Sunyer J, Kauffmann F, Bousquet J, Anto JM. Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts: an allergic comorbidity cluster. Allergy 2015; 70: 973-984.

46. Groupe detude M-L, Groupe d'etude M-L. In Process Citation. Presse medicale (Paris, France : 1983) 2015; 44 Suppl 1: S6-S22.

47. Groupe detude M-L, Groupe d'etude M-L. In Process Citation. Presse medicale (Paris, France : 1983) 2015; 44 Suppl 1: S1-5.

48. Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clinical and translational allergy 2015; 5: 36-36.

49. Ibanez G, Bernard JY, Rondet C, Peyre H, Forhan A, Kaminski M, Saurel-Cubizolles M-J, Grp EM-CCS. Effects of Antenatal Maternal Depression and Anxiety on Children's Early Cognitive Development: A Prospective Cohort Study. Plos One 2015; 10.

50. Just J. Allergic phenotypes in children. Revue Francaise D Allergologie 2015; 55: 108-109.

51. Just J, Amat F, Deschildre A. Food allergy phenotypes: experiences of the cohorts. Revue Francaise D Allergologie 2015; 55: 474-479.

52. Just J, Saint Pierre P, Amat F, Gouvis-Echraghi R, Lambert-Guillemot N, Guiddir T, Maesano IA. What lessons can be learned about asthma phenotypes in children from cohort studies? Pediatric Allergy and Immunology 2015; 26: 300-305.

53. Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O'Hehir R, Kleine-Tebbe J, Muraro A, Lack G, Larenas D, Levin M, Nelson H, Pawankar R, Pfaar O, van Ree R, Sampson H, Santos AF, Du Toit G, Werfel T, van Wijk RG, Zhang L, Akdis CA. International consensus on allergy immunotherapy. Journal of Allergy and Clinical Immunology 2015; 136: 556-568.

54. Kleine-Tebbe JR, Moen K, Rehm D, Demoly PM. The HDM Slit-Tablet Reduces Symptoms of House Dust Mite Allergic Rhinitis Independently of Asthma Status and Allergen Sensitisation Type; A Subgroup Analysis of Results from a Dbpc Phase III Trial (MERIT). Journal of Allergy and Clinical Immunology 2015; 135: AB268-AB268.

55. Klimek L, Hoffmann HJ, Renz H, Demoly P, Werfel T, Matricardi PM, Muraro A, Schmid-Grendelmeier P, Cardona V, Papadopoulos NG. Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective. Allergy 2015; 70: 1329-1331.

56. Maio S, Sarno G, Baldacci S, Annesi-Maesano I, Viegi G. Air quality of nursing homes and its effect on the lung health of elderly residents. Expert Review of Respiratory Medicine 2015; 9: 671-673.

57. Melchior M, Hersi R, van der Waerden J, Larroque B, Saurel-Cubizolles MJ, Chollet A, Galera C, Grp EM-CCS. Maternal tobacco smoking in pregnancy and children's socio-emotional development at age 5: The EDEN mother-child birth cohort study. European Psychiatry 2015; 30: 562-568.

58. Moneret-Vautrin AD, Deschildre A, Just J, Bruyere O, van Der Brempt X, Beaudouin E, Elegbede F, Crepet A. Mirabel Project: Description of a French Population of 785 Peanut Allergic or Sensitized Patients. Journal of Allergy and Clinical Immunology 2015; 135: AB34-AB34.

59. Nakhle MM, Farah W, Ziade N, Abboud M, Coussa-Koniski M-L, Annesi-Maesano I. Beirut Air Pollution and Health Effects - BAPHE study protocol and objectives. Multidisciplinary respiratory medicine 2015; 10: 21-21.

60. Nakhle MM, Farah W, Ziade N, Abboud M, Salameh D, Annesi-Maesano I. Short-term relationships between emergency hospital admissions for respiratory and cardiovascular diseases and fine particulate air pollution in Beirut, Lebanon. Environmental Monitoring and Assessment 2015; 187.

61. Papadopoulos NG, Bernstein JA, Demoly P, Dykewicz M, Fokkens W, Hellings PW, Peters AT, Rondon C, Togias A, Cox LS. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy 2015; 70: 474-494.

62. Pitsios C, Demoly P, Bilo MB, van Wijk RG, Pfaar O, Sturm GJ, Rodriguez del Rio P, Tsoumani M, Gawlik R, Paraskevopoulos G, Rueff F, Valovirta E, Papadopoulos NG, Calderon MA. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy 2015; 70: 897-909.

63. Price D, Smith P, Hellings P, Papadopoulos N, Fokkens W, Muraro A, Murray R, Chisholm A, Demoly P, Scadding G, Mullol J, Lieberman P, Bachert C, Mosges R, Ryan D, Bousquet J. Current controversies and challenges in allergic rhinitis management. Expert review of clinical immunology 2015; 11: 1205-1217.

64. Roussel C, Brabant S, Birnbaum J, Bourrain JL, Demoly P, Duhamel A, Wallaert B. Yellow jacket venom immunotherapy: The influence of maintenance dose on the immunologic response. Revue Francaise D Allergologie 2015; 55: 280-287.

65. Saadeh D, Salameh P, Caillaud D, Charpin D, De Blay F, Kopferschmitt C, Lavaud F, Annesi-Maesano I, Baldi I, Raherison C. Prevalence and association of asthma and allergic sensitization with dietary factors in schoolchildren: data from the french six cities study. Bmc Public Health 2015; 15.

66. Schrijvers R, Chiriac AM, Demoly P. Allergy Workup for Suspected Folic Acid Hypersensitivity. Journal of Investigational Allergology and Clinical Immunology 2015; 25: 233-236.

67. Schrijvers R, Gilissen L, Chiriac AM, Demoly P. Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back. Clinical and translational allergy 2015; 5: 31-31.

68. Sigsgaard T, Forsberg B, Annesi-Maesano I, Blomberg A, Bolling A, Boman C, Bonlokke J, Brauer M, Bruce N, Heroux M-E, Hirvonen M-R, Kelly F, Kuenzli N, Lundback B, Moshammer H, Noonan C, Pagels J, Sallsten G, Sculier J-P, Brunekreef B. Health impacts of anthropogenic biomass burning in the developed world. European Respiratory Journal 2015; 46: 1577-1588.

69. Tanno LK, Calderon M, Papadopoulos NG, Demoly P, of EWTfoaGC, Hypersensitivity/Allergic d. Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs. Clinical and translational allergy 2015; 5: 20-20.

70. Tanno LK, Calderon MA, Demoly P. Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11. Asia Pacific allergy 2015; 5: 193-196.

71. Tanno LK, Calderon MA, Goldberg BJ, Gayraud J, Bircher AJ, Casale T, Li J, Sanchez-Borges M, Rosenwasser LJ, Pawankar R, Papadopoulos NG, Demoly P. Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by crowdsourcing the allergist community. Allergy 2015; 70: 609-615.

72. van der Waerden J, Galera C, Larroque B, Saurel-Cubizolles M-J, Sutter-Dallay A-L, Melchior M, Grp EM-CCS. Maternal Depression Trajectories and Children's Behavior at Age 5 Years. Journal of Pediatrics 2015; 166: 1440-+.

73. Villani A, Demoly P, Nicolas J-F. Drug hypersensitivity: definitions and mechanisms. La Revue du praticien 2015; 65: 969-971.

74. Wang Y, Qi S, Zhu R, Chiriac AM, Demoly P. Which clinical indicators for the control of allergic rhinitis? Revue Francaise D Allergologie 2015; 55: 194-195.

75. Zugna D, Galassi C, Annesi-Maesano I, Baiz N, Barros H, Basterrechea M, Correia S, Duijts L, Esplugues A, Fantini MP, Forastiere F, Gascon M, Gori D, Inskip H, Larsen PS, Mommers M, Andersen A-MN, Penders J, Petersen MS, Pike K, Porta D, Sonnenschein-van der Voort A, Steuerwald U, Sunyer J, Torrent M, Vrijheid M, Richiardil L, Rusconi F. Maternal complications in pregnancy and wheezing in early childhood: a pooled analysis of 14 birth cohorts. International Journal of Epidemiology 2015; 44: 199-208.